Aurinia Pharmaceuticals(AUPH) - 2024 Q3 - Earnings Call Transcript

Aurinia Pharmaceuticals, Inc. (NASDAQ:AUPH) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Andrea Christopher - Head, Corporate Communications & IR Peter Greenleaf - President, CEO & Director Greg Keenan - Chief Medical Officer Joe Miller - CFO Conference Call Participants Stacy Ku - TD Cowen Maurice Raycroft - Jefferies Olivia Brayer - Cantor Fitzgerald Will Soghikian - Leerink Partners Operator Greetings, and welcome to Aurinia Pharmaceuticals Third Quarter 2024 Earnings ...